PMS2 and neoplasm: Immunohistochemical analysis was performed on diagnostic biopsy material from the primary tumor in a paraffin-embedded histological block from 2022, demonstrating the retention of MSH2, MSH6, MLH1, and PMS2 protein expression in viable tumor cells (Figure 3).